Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-010835

Executive VP Global Operations sold 3,192 shares at $17.67 ($56,399)

  • Executive VP Global Operations acquired 9,280 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

de Notaristefani Carlo · Executive VP Global Operations

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-14 Exercise or conversion : show line 1 in the form +9,280 21,400.73 D
2019-02-14 Sale : show line 2 in the form −3,192 $17.67 $56,399 18,208.73 D
Open-market sales · 3,192 sh · avg $17.67 · $56,399

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-14 Exercise or conversion : show line 3 in the form Restricted Share Units −9,280 18,560 D
Loading xslF345X03/doc4.xml…